Hydroxychloroquine in lupus erythematosus, a new horizon of the old drug

Fukumi Furukawa

Keywords


hydroxychloroquine; upus erythematosus

Full Text:

PDF

References


Hirakawa Y, Okuno A, Kimura D, et al. Hydroxychloroquine enhanced urticarial reaction in a patient with discoid lupus erythematosus. Trends Immunother 2017; 1(3). doi: 10.24294/ti.v1.i3.125. In Press.

Kuhn A, Ruland V, Bonsmann G. Cutaneous lupus erythematosus: Update of therapeutic options part I. J Am Acad Dermatol 2011; 65(6): e179–193. doi: 10.1016/j.jaad.2010.06.017.

Chang AY, Werth VP. Treatment of cutaneous lupus. Curr Rheumatol Rep 2011; 13(4): 300–307. doi: 10.1007/s11926-011-0180-z.

Furukawa F. Practical therapeutics for skin lesions of Japanese patients with discoid lupus erythematosus. Expert Opin Orphan Drugs 2014; 2(5): 477–482. doi: 10.1517/21678707.2014.901166.

Yokogawa N, Eto H, Tanikawa A, et al. Effects of hydroxychloroquine in patients with cutaneous lupus erythematosus: A multi-center, double-blind, randomized, parallel-group trial. Arthritis Rheumatol 2017; 69(4): 791–799. doi: 10.1002/art.40018.

Yokogawa N, Tanikawa A, Amagai M, et al. Response to hydroxychloroquine in Japanese patients with lupus-related skin disease using the cutaneous lupus erythematosus disease area and severity index (CLASI). Mod Rheumatol 2013; 23(2): 318–322. doi: 10.1007/s10165-012-0656-3.

Wallace DJ, Gudsoorkar VS, Weisman MH, et al. New insights into mechanisms of therapeutic effects of antimalarial agents in SLE. Nat Rev Rheumatol 2012; 8(9): 522–533. doi: 10.1038/nrrheum.2012.106.

Alves P, Bashir MM, Wysocka M, et al. Quinacrine suppresses tumor necrosis factor-α and IFN-α in dermatomyositis and cutaneous lupus erythematosus. J Invest Dermatol Symp Proc 2017; 18(2): S57–S63. doi: 10.1016/j.jisp.2016.11.001.

Shimomatsu T, Kanazawa N, Mikita N, et al. The effect of hydroxychloroquine on lupus erythematosus-like skin lesions in MRL/lpr mice. Mod Rheumatol 2016; 26(5): 744–748. doi: 10.3109/14397595.2016.1140711.

Inaba Y, Kanazawa N, Yoshimasu T,et al. Severer lupus erythematosus-like skin lesions in MRL/lpr mice with homozygous Kitwsh/wsh mutation. Mod Rheumatol 2017. doi: 10.1080/14397595.2017.1341591. In Press.

Mikita N, Inaba Y, Yoshimasu T, et al. Mast cells in collagen diseases. Trends Immunother 2017; 1(2): 75–81. doi: 10.24294/ti.v1.i2.96.




DOI: http://dx.doi.org/10.24294/ti.v1.i3.127

Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 Fukumi Furukawa

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.